Aspire-Lakewood Holdings Inc. (ASBP)
NASDAQ: ASBPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
ASBP stock chart
Technical analysisKey statistics
All statistics- Market cap
- $10.00M
- EPS (TTM)
- -$30.89
- Dividend yield
- None
- 52-week range
- 0.11 – 9.50
- Day range
- 7.10 – 8.12
- Volume / Avg
- 24.03K / 29.24K
- Beta
- —
- Shares outstanding
- 1.40M
52-week range
ASBP stock today
Aspire-Lakewood (ASBP) closed at $7.13 on Nov 20, down 5.44% (-$0.41), versus the S&P 500's 3.70% decline. At this level, ASBP sits in the middle of its 52-week range of $0.11 to $9.50: 24.9% below the high, set on Sep 4, 2026 and 6381.8% above the low. ASBP is up 35.0% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 83.8%.
Aspire-Lakewood has posted a net loss over the last twelve months (EPS of -$30.89), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Aspire-Lakewood
Company profileAspire-Lakewood Holdings, Inc. develops sublingual drug delivery technology and manufactures automotive and industrial control systems. The company develops a nano-technology-based sublingual drug delivery system designed to enhance the pharmacokinetic performance of active pharmaceutical ingredients, supplements, and nutraceuticals to increase bioavailability, improve speed of onset, and reduce side effects.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Kraig T. Higginson
- Headquarters
- Estero, FL
- IPO year
- 2022
- Website
- aspirelakewoodholdings.com
Financial highlights
Full financialsIn fiscal 2025, Aspire-Lakewood generated $6,202 in revenue. Aspire-Lakewood reported a net loss of $24.5 million, compared with a loss of $1.3 million a year earlier. Gross margin was -1.9% and operating margin -312016.9%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Revenue | $6.20K | — | — | — |
| Growth | — | — | — | — |
| Net income | $-24.48M | $-1.31M | $4.46M | $3.34M |
| EPS (diluted) | $-16.38 | $-1.90 | — | — |
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 20, 2026
- EPS actual vs est.
- $-48.05 vs —
Aspire-Lakewood peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| RADXRadiopharm Theranostics Limited ADR | 0.6304 | -9.71% | $9.90M | vs ASBP |
| AEONAEON Biopharma Inc. Class A | 0.123 | -7.59% | $10.35M | vs ASBP |
| CMMBChemomab Therapeutics Ltd. ADR | 1.19 | +4.39% | $9.58M | vs ASBP |
| BFRIBiofrontera Inc. | 0.53 | -7.02% | $9.51M | vs ASBP |
| GDTCCytoMed Therapeutics Limited | 0.755 | -2.33% | $9.01M | vs ASBP |
| CALCCalciMedica Inc. | 1.26 | +7.69% | $8.69M | vs ASBP |
| OPTHOptimi Health Corp. | 1.51 | -13.71% | $8.65M | vs ASBP |
| BIVIBioVie Inc. Class A | 0.80 | -12.07% | $8.58M | vs ASBP |
Indexes, lists and sector
Aspire-Lakewood stock FAQ
What is Aspire-Lakewood's stock price today?
ASBP last traded at $7.13 as of Nov 20, 4:00 PM EST, down 5.44% on the day. Prices are delayed at least 15 minutes.
Does Aspire-Lakewood pay a dividend?
No. Aspire-Lakewood does not currently pay a regular cash dividend.
Who is Aspire-Lakewood's CEO?
Mr. Kraig T. Higginson is the chief executive officer of Aspire-Lakewood Holdings Inc..
Has ASBP ever split its stock?
Yes. The most recent ASBP stock split was a 1-for-40 split on Jan 16, 2026.
What is the ASBP 52-week high?
The 52-week high for ASBP is $9.50 and the 52-week low is $0.11. The stock is currently 24.9% below its high.